Franklin Genomic Advancements ETF Rating

$39.77 -1.06 (-2.60%)
Closing price 11/20/2026 04:10 PM Eastern
Extended Trading
$39.81 +0.04 (+0.10%)
As of 11/20/2026 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Franklin Genomic Advancements ETF Aggregate Rating and Price Target (2026)

MarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.

HELX Aggregate Rating

Moderate Buy
2.77

Holdings in HELX have an aggregate rating of Moderate Buy based on 423 analyst ratings issued in the past year covering 24 companies (72.5% of the portfolio).

HELX Aggregate Price Target

$39.77
High Prediction$39.77
Average Prediction$39.77
Low Prediction$39.77

Holdings in HELX have an aggregate price target of $39.77 and a range of $39.77 to $39.77 covering 24 companies (72.5% of the portfolio).

HELX Consensus Ratings of Holdings

Strong Buy
0 Strong Buy rating(s)
Buy
1 Buy rating(s)
Moderate Buy
19 Moderate Buy rating(s)
Hold
4 Hold rating(s)
Reduce
0 Reduce rating(s)
Sell
0 Sell rating(s)
Strong Sell
0 Strong Sell rating(s)

Ratings for Stocks Held by Franklin Genomic Advancements ETF

 
 
Strong Sell
Sell
Reduce
Hold
Moderate Buy
Buy
Strong Buy

Ratings for the Top 24 HELX Holdings

Weight In ETFCompanyShare PriceConsensus RatingConsensus Price TargetPossible UpsideNumber of RatingsMarketRank™Indicator(s)View
Ratings
8.56%
Guardant Health, Inc. stock logo
GH
Guardant Health
$145.83
+0.2%
Moderate Buy$191.48 31.3%26
3.7592 of 5 stars
8.02%
Natera, Inc. stock logo
NTRA
Natera
$273.08
-5.8%
Moderate Buy$396.93 45.4%23
2.8666 of 5 stars
5.08%
Adaptive Biotechnologies Corporation stock logo
ADPT
Adaptive Biotechnologies
$27.90
-0.5%
Moderate Buy$30.31 8.6%8
2.2316 of 5 stars
4.80%
Krystal Biotech, Inc. stock logo
KRYS
Krystal Biotech
$308.58
-2.3%
Moderate Buy$375.00 21.5%14
3.2896 of 5 stars
4.61%
Ligand Pharmaceuticals Incorporated stock logo
LGND
Ligand Pharmaceuticals
$286.87
0.0%
Moderate Buy$355.38 23.9%9
3.7715 of 5 stars
3.41%
BridgeBio Pharma, Inc. stock logo
BBIO
BridgeBio Pharma
$76.03
-2.8%
Moderate Buy$104.42 37.3%22
2.8328 of 5 stars
3.39%
Twist Bioscience Corporation stock logo
TWST
Twist Bioscience
$103.23
-7.5%
Hold$133.92 29.7%12
2.7769 of 5 stars
2.87%
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$609.38
-3.9%
Hold$649.27 6.5%13
2.8585 of 5 stars
2.81%
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$1,346.40
-0.3%
Moderate Buy$1,422.00 5.6%30
3.9509 of 5 stars
2.78%
United Therapeutics Corporation stock logo
UTHR
United Therapeutics
$554.73
-0.8%
Moderate Buy$676.40 21.9%16
4.6357 of 5 stars
2.76%
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
$514.76
-1.1%
Moderate Buy$596.44 15.9%28
3.7978 of 5 stars
2.52%
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
$920.69
-0.3%
Moderate Buy$904.41 -1.8%31
3.7486 of 5 stars
2.40%
Travere Therapeutics, Inc. stock logo
TVTX
Travere Therapeutics
$46.99
-2.7%
Moderate Buy$72.55 54.4%13
3.6695 of 5 stars
2.15%
Vylor stock logo
VYLR
Vylor
$68.11
+0.5%
Moderate Buy$82.54 21.2%16
3.8125 of 5 stars
2.12%
Tempus AI, Inc. stock logo
TEM
Tempus AI
$53.98
-9.5%
Hold$79.37 47.0%22
3.1188 of 5 stars
2.12%
CareDx, Inc. stock logo
CDNA
CareDx
$69.85
-2.9%
Moderate Buy$70.33 0.7%9
1.3266 of 5 stars
1.88%
Repligen Corporation stock logo
RGEN
Repligen
$163.81
-3.8%
Moderate Buy$178.57 9.0%18
2.6964 of 5 stars
1.83%
GRAIL, Inc. stock logo
GRAL
GRAIL
$99.11
-5.5%
Hold$128.80 30.0%12
2.843 of 5 stars
1.74%
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
$150.57
-3.8%
Moderate Buy$202.59 34.5%24
4.8908 of 5 stars
1.74%
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
$314.29
-4.2%
Moderate Buy$311.67 -0.8%16
2.2602 of 5 stars
1.43%
Jazz Pharmaceuticals PLC stock logo
JAZZ
Jazz Pharmaceuticals
$230.40
-2.6%
Moderate Buy$294.25 27.7%20
4.7191 of 5 stars
1.21%
Praxis Precision Medicines, Inc. stock logo
PRAX
Praxis Precision Medicines
$300.43
-3.4%
Moderate Buy$660.50 119.9%22
3.1519 of 5 stars
1.17%
Kiniksa Pharmaceuticals International, plc stock logo
KNSA
Kiniksa Pharmaceuticals International
$93.89
+0.4%
Moderate Buy$102.38 9.0%10
3.4545 of 5 stars
1.13%
Royalty Pharma PLC stock logo
RPRX
Royalty Pharma
$68.47
+1.1%
Buy$65.00 -5.1%9
3.5413 of 5 stars

This page (BATS:HELX) was last updated on 11/21/2026 by MarketBeat.com Staff.
From Our Partners